GYRE · Gyre Therapeutics, Inc.
Market Cap
$714.78M
Shares
111.51M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-14 | 516 | $6.54 | $3,375 |
| 2026-08-07 | 337 | $6.40 | $2,157 |
| 2026-08-05 | 1,278 | $6.15 | $7,860 |
| 2026-08-04 | 1,253 | $6.11 | $7,656 |
| 2026-07-24 | 2,721 | $6.01 | $16,353 |
| 2026-07-23 | 2,921 | $5.94 | $17,351 |
| 2026-07-20 | 4,704 | $6.05 | $28,459 |
| 2026-07-17 | 2,438 | $6.42 | $15,652 |
| 2026-07-15 | 2,548 | $6.34 | $16,154 |
| 2026-07-14 | 8,545 | $6.34 | $54,175 |
| 2026-07-13 | 8,430 | $6.52 | $54,964 |
| 2026-07-09 | 4,110 | $6.86 | $28,195 |
| 2026-07-08 | 1 | $7.01 | $7 |
| 2026-07-07 | 332 | $7.26 | $2,410 |
| 2026-07-06 | 24 | $7.34 | $176 |
| 2026-07-02 | 5,505 | $6.52 | $35,893 |
| 2026-06-30 | 275 | $6.45 | $1,774 |
| 2026-06-26 | 1,675 | $6.23 | $10,435 |
| 2026-06-25 | 171 | $6.48 | $1,108 |
| 2026-06-22 | 1,629 | $6.25 | $10,181 |
| 2026-06-18 | 713 | $6.08 | $4,335 |
| 2026-06-15 | 4,871 | $5.93 | $28,885 |
| 2026-06-11 | 1,188 | $5.95 | $7,069 |
| 2026-06-10 | 4,226 | $6.13 | $25,905 |
| 2026-06-08 | 3,344 | $6.29 | $21,034 |
| 2026-06-05 | 5,643 | $6.19 | $34,930 |
| 2026-06-03 | 8,980 | $5.56 | $49,929 |
Showing 1–27 of 27 settlements
Key facts
CIK
1124105
CUSIP
403783103
13F (30d)
46 filings
46 filers
Visit website
Investor relations